Browse the complete record of transactions filed by Ajer Jeffrey Robert, Directeur et Directeur Exécutif Commercial. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 11 filings have been published. Total volume traded: €358k. The latest transaction was filed on 3 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Jeffrey Robert Ajer serves as Director and EVP, Chief Commercial Officer at Nektar Therapeutics and Biomarin Pharmaceutical Inc. He is responsible for commercial strategy and business development, contributing to the growth of both companies in the biopharmaceutical sector.